DaVita, Inc. (DVA)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about DaVita, Inc. (DVA)
Go deeper and ask any question about DVA
Company Performance
Current Price
as of Sep 18, 2024$163.16
P/E Ratio
17.36
Market Cap
$13.69B
Description
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Metrics
Overview
- HQDenver, CO
- SectorHealth Services
- IndustryMedical/Nursing Services
- TickerDVA
- Price$163.16-0.65%
Trading Information
- Market Cap$13.69B
- Float95.57%
- Average Daily Volume (1m)699,575
- Average Daily Volume (3m)793,592
- EPS$9.66
Company
- Revenue$12.52B
- Rev Growth (1yr)6.21%
- Net Income$222.68M
- Gross Margin27.26%
- EBITDA Margin21.23%
- EBITDA$676.58M
- EV$25.27B
- EV/Revenue2.02
- P/E17.36
- P/S1.16